文献速递肿瘤 PET/CT神经核医学

双PET显像在支气管神经内分泌肿瘤中的预后价值:NETPET评分

Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker.
PubMed 文献 · J Nucl Med · 2021-02-12

NETPET评分由经验丰富的核医学医师判定,单因素分析显示NETPET评分与总生存显著相关(P=0.003),多因素分析仅NETPET评分保持显著(P=0.03),且与组织学分级显著相关(P=0.006)。

要点

  • NETPET评分与支气管神经内分泌肿瘤总生存显著相关,多因素分析中为独立预后因素。
  • NETPET评分与组织学分级显著相关(P=0.006),可辅助分级评估。
  • 该评分在支气管NEN中预后价值与胃肠胰NEN一致,但需前瞻性验证。

核心结论

  • NETPET评分是支气管神经内分泌肿瘤的预后生物标志物,与胃肠胰NEN中的效果一致。

主要发现

  • 单因素分析中NETPET评分与总生存显著相关(P=0.003),组织学亦显著相关(P=0.01)。
  • 多因素分析中仅NETPET评分保持显著(P=0.03)。
  • NETPET评分与组织学分级显著相关(P=0.006,χ2检验)。

关键数值与推荐

  • NETPET评分由经验丰富的核医学医师根据两种PET示踪剂摄取判定。

临床怎么用

  • 对晚期支气管NEN患者,可结合18F-FDG与68Ga-DOTATATE双PET显像计算NETPET评分以辅助预后分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PET scans using 18F-FDG and somatostatin receptor imaging agents are both used in imaging of neuroendocrine neoplasms (NENs). We have suggested the "NETPET score," using uptake of both PET tracers, as a prognostic biomarker in NENs. The name NETPET score was suggested previously to capture the score's intent to summarize information from dual PET imaging in neuroendocrine tumors. We previously demonstrated the effectiveness of the NETPET score in gastroenteropancreatic NENs (GEPNENs). Its prognostic relevance in bronchial NENs remains undetermined. Methods: This is a retrospective multicenter study (2011-2018) assessing patients who had advanced bronchial NEN and who underwent both 18F-FDG and 68Ga-DOTATATE PET within 60 d of each other. The NETPET score was assigned by experienced nuclear medicine physicians and compared with other clinical data such as World Health Organization grade. The primary outcome was overall survival; NETPET score and other prognostic variables were analyzed using univariate and multivariate analyses by the Cox proportional-hazards model. Results: Thirty-eight patients were included for review. The NETPET score and histology were significantly correlated with overall survival in univariate analyses (P = 0.003, P = 0.01). On multivariate analysis, only the NETPET score remained significant (P = 0.03). The NETPET score was significantly associated with histologic grade (P = 0.006, χ2 test). Conclusion: The NETPET score is a prognostic biomarker in bronchial NENs as well as GEPNENs. Although it needs to be validated in prospective studies, it holds significant promise as a biomarker for a wide range of NENs.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Chan DL, Ulaner GA, Pattison D, et al. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker. J Nucl Med. 2021. PMID: 33579809. doi:10.2967/jnumed.120.257659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。